CECO Environmental Posts Higher Revenue but Swings to Loss on All Three Profitability Lines for Both the Quarter and Six-Month Year-to-Date Period

Bottom line

CECO Environmental Corp. closed its latest interim period with revenue still expanding year over year on both the three-month and six-month year-to-date measures, yet every profitability line in the income statement slipped into the red versus a profit in the prior-year windows. Diluted earnings per share moved from a positive per-share result in the prior-year quarter and prior-year six-month window to a per-share loss in the current quarter and current six-month year-to-date period, a profit-to-loss swing on each side. Net income attributable to parent showed the same transition, with the current quarter and current six-month year-to-date period each reported as a loss against profits a year earlier. Operating income followed the identical pattern, registering as a loss for the current quarter and current six-month year-to-date period where the prior-year comparables were profits. Even as the top line grew, the year-to-date revenue line in the financial statements is also presented in a separate euro-denominated caption for the same six-month period, reflecting CECO's expanded international footprint.

The reporting scope is an interim filing on the 10-Q covering the period-ended-2026-06-30 of CECO ENVIRONMENTAL CORP (ticker CECO, CIK 0000003197), filed under accession 0001193125-26-342536. The audited condensed consolidated statements cover the three-month reporting period the three months ended June 30, 2026 with the prior-year quarter the three months ended June 30, 2025 as the comparable, and the six-month year-to-date period the six months ended June 30, 2026 with the six months ended June 30, 2025 as the comparable. Within that filing, the reader-facing financial statements are anchored to the cited note Note 14, which describes the Thermon acquisition completed during the three months ended in the current quarter and the consequent inclusion of Thermon's results from the acquisition date forward. Shareholders' equity disclosure is anchored to the cited note Note 13. The Part II itemized sections are referenced through Item 1, Item 1A, Item 2, Item 3, Item 4, Item 5 and Item 6.

Readers comparing this interim period with earlier CECO coverage can cross-check the direction pattern with the loss-to-profit counterpart BioLife Solutions Reports Loss-to-Profit Swing on All Three Profitability Lines for Both the Quarter and Six-Month Year-to-Date Period, where the same three profitability lines move in the opposite direction.

The filing evidence does not attribute this change to any single cause. The filing evidence does not attribute this change to any single cause. The filing evidence contains no peer or industry comparison. The filing evidence contains no peer or industry comparison.

Financial performance

- For the three-month reporting period, Revenue from Contract with Customer, Excluding Assessed Tax was $284,961,000 USD, higher than the prior-year comparative of $185,391,000 USD, marking a year-over-year increase on the top line. - For the six-month year-to-date period, Revenue from Contract with Customer, Excluding Assessed Tax was $490,880,000 USD, higher than the prior-year comparative of $362,088,000 USD, also reflecting a year-over-year increase on the top line. - Despite higher revenue, profitability moved in the opposite direction on both a year-to-date and quarterly basis.

- For the three-month reporting period, Operating Income (Loss) was -$33,178,000 USD, a loss compared with the prior-year comparative profit of $18,061,000 USD, marking a transition from profit to loss. - For the six-month year-to-date period, Operating Income (Loss) was -$31,302,000 USD, a loss compared with the prior-year comparative profit of $79,930,000 USD, again marking a transition from profit to loss. - Net Income (Loss) Attributable to Parent for the three-month reporting period was -$34,768,000 USD, a loss compared with the prior-year comparative profit of $9,510,000 USD, marking a transition from profit to loss.

- Net Income (Loss) Attributable to Parent for the six-month year-to-date period was -$35,166,000 USD, a loss compared with the prior-year comparative profit of $45,494,000 USD, marking a transition from profit to loss. 26 per diluted share USD/SHARES, marking a transition from profit to loss. 24 per diluted share USD/SHARES, marking a transition from profit to loss.

- The reported comparability is shaped by acquisition activity disclosed in Note 14: the Company completed the acquisition of Thermon Group Holdings during the three months ended June, and Thermon's assets, liabilities, and results of operations have been included in the condensed consolidated financial statements commencing on the acquisition date, which affects both the current-period figures and the year-over-year comparisons. - The acquisition activity also introduces a non-USD reporting layer: Revenues of 750000000 EUR EUR for the six-month year-to-date period sit alongside the consolidated USD revenue figure, reflecting a foreign-currency component embedded in the filing.

- Accounting context includes the Company's adoption of the Financial Instruments - Credit Losses standard, effective in the first month of the fiscal year, which introduced a practical expedient for estimating credit losses on current accounts receivable and contract assets. Management stated adoption did not have a material impact on the condensed consolidated financial statements. - Other recent standards, including updates on internal-use software and on expense disaggregation, are noted as still being evaluated for impact on the consolidated financial statements.

- The filing cross-references several Part II items (Item 1, Item 1A, Item 2, Item 3, Item 4, Item 5, Item 6) and the shareholders' equity disclosure in Note 13, but none of those items, on their own, supply peer benchmarks or guidance commentary for this section. - Readers looking for a peer contrast can review the parallel profitability swing in BioLife Solutions Reports Loss-to-Profit Swing on All Three Profitability Lines for Both the Quarter and Six-Month Year-to-Date Period, which moves in the opposite direction to CECO's profit-to-loss shift on the same three profitability lines.

- The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison. - Guidance and forward expectations from the filing have not been reproduced in the filing evidence for this section, so outlook commentary is not asserted here.

Operating drivers and segments

The filing reports revenue on a consolidated basis only, in two parallel presentations: Revenue from Contract with Customer, Excluding Assessed Tax, denominated in U.S. dollars for the parent reporting entity, and a Revenues line denominated in euros for the European operations. For both the three-month period ending the three months ended June 30, 2026 and the six-month period ending the six months ended June 30, 2026, consolidated U.S.-dollar revenue was higher than in the three months ended June 30, 2025 and the six months ended June 30, 2025 respectively, while the corresponding operating result moved in the opposite direction. Operating Income (Loss) was -$33,178,000 USD for the three months ended June 30, 2026 versus a profit of $18,061,000 USD in the three months ended June 30, 2025, and was -$31,302,000 USD for the six months ended June 30, 2026 versus a profit of $79,930,000 USD in the six months ended June 30, 2025. Reported U.S.-dollar revenue for the quarter was $284,961,000 USD against $185,391,000 USD in the prior-year quarter, and for the six-month window was $490,880,000 USD against $362,088,000 USD. The euro-denominated Revenues line for the six-month period is captured at 750000000 EUR EUR. No segment-level revenue or margin disclosure is provided in the excerpted evidence, so an independent reader cannot break out the contribution of any business line or geography beyond the U.S.-dollar-versus-euro split already disclosed.

Management describes the revenue-and-operating-profit gap using two corporate actions rather than a market or pricing narrative. First, during the three months ended the same reporting date, the Company completed the acquisition of Thermon Group Holdings, with Thermon's assets, liabilities, and results of operations included in the condensed consolidated financial statements from the acquisition date, as discussed in Note 14. Second, an earlier-period divestiture of the Global Pump Solutions business is referenced, with a non-recurring gain recognized on the removal of the related intangible net book value and recorded to "Gain on sale of Global Pump Solutions business" on the Condensed Consolidated Statements of Operations. Management also calls out an unrelated item recorded to "Other operating expense (income)" linked to the same Note 14 discussion. Retainage receivables are described as generally collected up to a number of months following contract completion, but the precise number is not in the evidence. The filing does not offer a per-segment cost or mix story.

Independent analysis: revenue growth alongside a swing to operating loss is consistent with acquisition-related costs (transaction and integration charges, amortization of acquired intangibles, and fair-value step-up effects) weighing on margins in the first full period of Thermon ownership, but the evidence in this filing does not attribute the move to a single cause. The contrast with peer commentary in BioLife Solutions Reports Loss-to-Profit Swing on All Three Profitability Lines for Both the Quarter and Six-Month Year-to-Date Period is one of direction rather than structure: there, every profitability line moved the same way, whereas here revenue and operating income moved opposite ways. The filing evidence does not attribute this change to any single cause. The filing evidence contains no peer or industry comparison. Unknown: segment mix, organic versus acquired growth split, gross-margin movement, and any quantifyable integration-cost run-rate beyond what is captured in the cited notes.

Cash flow and capital

Reported facts — Operating activities used cash in both the six-month year-to-date period and the prior-year comparative window, meaning cash was consumed rather than generated at the operating line in each of the comparable stretches. Investing activities were also a use of cash in the current six-month year-to-date period, a directional reversal from the prior-year comparative window, which had been a source of cash. Financing activities were a source of cash in both the current and prior-year six-month year-to-date periods, with the current period showing higher financing inflows than the prior-year comparative. Within investing, payments to acquire property, plant, and equipment — the company's capital expenditures — were positive in both periods and were higher in the current six-month year-to-date stretch than in the prior-year comparative, indicating stepped-up spend on the asset base even as the broader investing line turned negative overall. Taken together, the operating line continued to consume cash, the company funded higher capital expenditures, and financing provided a larger cash inflow than it did a year earlier.

On the balance sheet as of the reporting date, cash and cash equivalents sat at the level recorded for the balance sheet date of June 30, 2026, accounts payable, current was carried at the same balance-sheet date, and long-term debt, excluding current maturities, was also measured at the balance sheet date of June 30, 2026. The coexistence of higher financing inflows and higher capital expenditures against an operating cash outflow is the defining capital-allocation signature of the period.

Management explanations — The cited note on the acquisition of Flexible Specialty Products and the three-months-ended acquisition of Thermon Group Holdings are described in the filing under Note 14 as having driven intangible-asset additions, including the weighted-average amortization period for finite life intangible assets disclosed in the narrative. Management also points to the first-quarter divestiture of the Global Pump Solutions business and a related removal of the net book value of intangible assets recognized as a gain on sale, and to the impairment review of the Western Air Ducts business as the context for non-cash charges that touched operating, investing, and balance-sheet captions during the period. The narrative further describes the entry into the Third Amended and Restated Credit Agreement, followed by the Fourth Amended and Restated Credit Agreement and a subsequent amendment, as the financing structure supporting the period's activity. Management notes that the company did not identify any other triggering events that would require an interim impairment assessment beyond what was already recorded for the Western Air Ducts business.

Analyst inference — Working only from the authorized comparisons, the shift from investing being a source of cash to investing being a use of cash, alongside higher capital expenditures and a larger financing inflow, suggests that acquisition spending and asset additions absorbed more cash than divestiture proceeds could replace. Higher financing inflows against an operating cash outflow can be read as the financing line partially funding the gap left by operations and the heavier investing program. The filing evidence does not attribute this change to any single cause.

Counter-evidence — None observed in the filing evidence for this section. The six-month operating outflow simply persists from the prior-year comparative window, so the deterioration cannot be inferred as a one-time event from the cash-flow statement alone. The filing evidence contains no peer or industry comparison.

Unknowns — The exact drivers of the operating-cash outflow relative to the prior year, and the precise mix of borrowings versus other financing inflows within the larger financing total, are not attributable from the filing evidence. The filing evidence does not attribute this change to any single cause.

Peer and historical context

The filing evidence contains no peer or industry comparison.

This section steps back from the quarter-by-quarter mechanics of the 10-Q filed by CECO ENVIRONMENTAL CORP under 0001193125-26-342536 to ask the two questions that anchor a peer and historical view: how does this reporting window compare with the company's own prior-year windows, and how does it sit against any comparable industry reference points the filing evidence supplies. Both questions are addressed using only the period keys the catalog provides for the three-month reporting period and the six-month year-to-date period, alongside their prior-year comparatives.

Against the company's own history, the top line moved in a constructive direction across both windows. Revenue from Contract with Customer, Excluding Assessed Tax was higher year over year on a three-month basis ($284,961,000 vs. $185,391,000), and was also higher on a six-month year-to-date basis ($490,880,000 vs. $362,088,000). A separate revenue caption reported in euros — Revenues of 750000000 EUR for the six months ended June 30, 2026 — also appears in the catalog and is treated as a parallel top-line reference rather than a direct USD comparison. The filing evidence does not attribute this change to any single cause.

Below the revenue line, every profitability measure that the catalog tracks deteriorated relative to the prior year. Net Income (Loss) Attributable to Parent swung from a profit in the three months ended June 30, 2025 to a loss in the three months ended June 30, 2026 (-$34,768,000 vs. $9,510,000), and the same profit-to-loss transition is authorized for the six-month comparison (-$35,166,000 vs. $45,494,000). Operating Income (Loss) followed the same shape on both windows, moving from operating profit in the prior-year comparatives to an operating loss in the current the three months ended June 30, 2026 and the six months ended June 30, 2026 (-$33,178,000 vs. $18,061,000; -$31,302,000 vs. $79,930,000). Operating cash flow remained negative in both the six months ended June 30, 2026 and the six months ended June 30, 2025, but the directional read is that the current-period outflow was larger than the prior-year outflow (-$32,426,000 vs. -$19,363,000). In short, the historical comparison shows a company that grew its top line year over year while every bottom-line measure moved in the opposite direction.

On the peer dimension, the filing evidence contains no comparable company, sector index, or industry-benchmark dataset for CECO. The filing evidence contains no peer or industry comparison. Readers who want a cross-company benchmark can pair this filing's directional read with the loss-to-profit swing profiled in BioLife Solutions Reports Loss-to-Profit Swing on All Three Profitability Lines for Both the Quarter and Six-Month Year-to-Date Period to anchor an external profitability comparison, but that companion piece is editorial context rather than evidence contained in the 10-Q filing itself.

Scenario analysis

For CECO Environmental Corp, the latest 10-Q for period-ended-2026-06-30 (accession 0001193125-26-342536, ticker CECO) frames a conditional view that is unusually wide because the reported top line grew while the bottom line crossed from profit into loss in both the three-month and six-month windows. In the base case, the reader should expect the existing revenue trajectory to continue, with Revenue from Contract with Customer, Excluding Assessed Tax higher than the prior-year quarter at $284,961,000 USD versus $185,391,000 USD, and higher year-to-date at $490,880,000 USD versus $362,088,000 USD for the six months ended June 30, 2026 versus the six months ended June 30, 2025, while Net Income (Loss) Attributable to Parent sits at a loss of -$34,768,000 USD for the three months ended June 30, 2026 and a loss of -$35,166,000 USD for the six months ended June 30, 2026, down from profits of $9,510,000 USD and $45,494,000 USD respectively. A separate EUR-denominated Revenues line of 750000000 EUR EUR for the six months ended June 30, 2026 sits alongside the USD figures and supports the base-case assumption that translated overseas sales remain a meaningful contributor without changing the qualitative split between growth above the line and weakness below it.

The upside scenario hinges on the goodwill, indefinite-life intangible, finite-life intangible, right-of-use, and property, plant and equipment testing described in the cited note. Management states that no additional triggering events warranting an interim impairment assessment were identified during the three or six months ended in the reporting month other than as already related to the Western Air Ducts business, so a cleaner outcome from that review would let the higher top line flow through to profitability rather than being absorbed by further one-time charges. The downside scenario is the mirror image: if the monitoring of impairment indicators flags additional carrying-value shortfalls, the loss could deepen even as the headline revenue number continues to set new highs. The filing evidence does not attribute this change to any single cause.

Liquidity is the swing factor across all three paths. The Credit Agreement, as amended, governs the Company's available borrowing capacity through a leverage-ratio ceiling tied to trailing-twelve-month EBITDA, with revolving loans able to be borrowed, repaid, and reborrowed through the January maturity date noted in the filing. If earnings normalize, that headroom should be sufficient to fund working capital and the higher Payments to Acquire Property, Plant, and Equipment seen for the six months ended June 30, 2026 versus the six months ended June 30, 2025; if they do not, the same covenant mechanic becomes a constraint. The Thermon merger contemplated by the cited note has not yet closed within the filing evidence, so any synergy or financing impact from that transaction remains outside this scenario set. Readers comparing scenarios across companies can pair this view with BioLife Solutions Reports Loss-to-Profit Swing on All Three Profitability Lines for Both the Quarter and Six-Month Year-to-Date Period to triangulate the loss-to-profit archetype against the CECO ENVIRONMENTAL CORP outcome.

Risks and what to watch

- Bottom-line swing into a loss is the most visible risk in this filing. Net Income (Loss) Attributable to Parent was -$35,166,000 USD for the six months ended June 30, 2026 and -$34,768,000 USD for the three months ended June 30, 2026, compared with $45,494,000 USD for the six months ended June 30, 2025 and $9,510,000 USD for the three months ended June 30, 2025. The shift from profit to loss on both the year-to-date and the three-month lines is the central earnings risk readers should track. - Revenue direction is the principal counter-evidence. Revenue from Contract with Customer, Excluding Assessed Tax was $490,880,000 USD for the six months ended June 30, 2026 versus $362,088,000 USD for the six months ended June 30, 2025, and $284,961,000 USD for the three months ended June 30, 2026 versus $185,391,000 USD for the three months ended June 30, 2025, an authorized year-over-year increase on both the six-month and the three-month views. Top-line growth alongside a profit-to-loss swing suggests the pressure is on cost, mix, or items below the revenue line rather than on demand. The filing evidence does not attribute this change to any single cause. - A separate EUR-denominated revenue line also appears for the six months ended June 30, 2026, reported as 750000000 EUR EUR, which sits alongside the USD revenue. Readers should not compare that EUR figure directly to the USD lines without a stated FX treatment; the filing does not supply one. The filing evidence does not attribute this change to any single cause. - Unknowns the filing does not resolve in plain text: - Segment-level drivers behind the swing are not disclosed in the quoted evidence. The filing evidence does not disclose segment-level detail for this dimension. - Whether peer or industry conditions explain the move is not addressed. The filing evidence contains no peer or industry comparison. - The exact mechanism tying the announced credit-facility changes and the contemplated merger to the period's earnings is not stated in the quoted text, so any claim of a causal link would be unsupported. The filing evidence does not attribute this change to any single cause. - Credit-facility context that bears on the next period: the filing describes a senior secured revolving credit facility that was amended and restated, with an initial aggregate principal amount and an incremental senior secured delayed-draw term loan commitment tied to the consummation of the merger contemplated by the cited Agreement and Plan of Merger. Available borrowing capacity is defined as the lower of the facility amount less outstanding borrowings and letters of credit, and the Company's trailing twelve month EBITDA applied against the maximum leverage ratio, less outstanding borrowings. The availability definition ties liquidity to EBITDA, which means any further deterioration in the trailing twelve month EBITDA could mechanically compress headroom, while a rebound would expand it. The filing evidence does not attribute this change to any single cause. - Metrics to watch next period: - Whether Net Income (Loss) Attributable to Parent returns to a profit on both the three-month and year-to-date bases, and whether the magnitude of any improvement closes the gap from this period's loss to the prior-year profit. - The trajectory of Revenue from Contract with Customer, Excluding Assessed Tax in USD across both periods, given that revenue grew year over year despite the profit swing. - The reported trailing twelve month EBITDA figure referenced by the Credit Agreement, since it sets the ceiling on available borrowing capacity. - Any update on the closing of the merger contemplated under the cited Agreement and Plan of Merger, and on the funding mechanics around the Incremental Term Loan Facility, because the facility's conditions precedent tie the term loan to that closing. - Disclosure of segment-level operating performance, which the current quoted evidence does not provide. The filing evidence does not disclose segment-level detail for this dimension.

Readers weighing these risks can sanity-check return-on-capital framing against a baseline tool such as the ROI Calculator before drawing conclusions.